Fleur Chandler chairs the Project HERCULES Steering Group. Fleur is a Health Economist with over 25 years’ experience in the pharmaceutical industry leading teams in health economics and health outcomes, and has a strong track record in Health Technology Assessment. She is also the mother of a teenager with DMD and sits on the Patient Advisory Board of Duchenne UK. She brought her personal and professional experience together to create the vision and concept for Project HERCULES and to guide the evidence generation activity to ensure that potential treatments for DMD are not denied on the basis of an inadequate HTA evidence base. Her current role is Head of Market Access UK and Ireland at Sanofi.